|Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of …|
N Galie, MM Hoeper, M Humbert, A Torbicki, JL Vachiery, JA Barbera, ...
European heart journal 30 (20), 2493-2537, 2009
|BTS guideline for emergency oxygen use in adult patients|
BR O’driscoll, LS Howard, AG Davison
Thorax 63 (Suppl 6), vi1-vi68, 2008
|Chronic thromboembolic pulmonary hypertension|
NH Kim, M Delcroix, DP Jenkins, R Channick, P Dartevelle, P Jansa, ...
Journal of the American College of Cardiology 62 (25 Supplement), D92-D99, 2013
|Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland|
Y Ling, MK Johnson, DG Kiely, R Condliffe, CA Elliot, JSR Gibbs, ...
American journal of respiratory and critical care medicine 186 (8), 790-796, 2012
|Treatment goals of pulmonary hypertension|
VV McLaughlin, SP Gaine, LS Howard, HH Leuchte, MA Mathier, S Mehta, ...
Journal of the American College of Cardiology 62 (25 Supplement), D73-D81, 2013
GP Diller, S van Eijl, DO Okonko, LS Howard, O Ali, T Thum, SJ Wort, ...
Circulation 117 (23), 3020-3030, 2008
|Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension|
M Toshner, R Voswinckel, M Southwood, R Al-Lamki, LSG Howard, ...
American journal of respiratory and critical care medicine 180 (8), 780-787, 2009
|Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights|
CJ Rhodes, LS Howard, M Busbridge, D Ashby, E Kondili, JSR Gibbs, ...
Journal of the American College of Cardiology 58 (3), 300-309, 2011
|BTS guideline for oxygen use in adults in healthcare and emergency settings|
BR O'driscoll, LS Howard, J Earis, V Mak
Thorax 72 (Suppl 1), ii1-ii90, 2017
|Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations|
S Ahmedzai, IM Balfour-Lynn, T Bewick, R Buchdahl, RK Coker, ...
Thorax 66 (Suppl 1), i1-i30, 2011
|Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension|
CJ Rhodes, J Wharton, LS Howard, JSR Gibbs, MR Wilkins
Heart 97 (13), 1054-1060, 2011
|Relating oxygen partial pressure, saturation and content: the haemoglobin–oxygen dissociation curve|
JA Collins, A Rudenski, J Gibson, L Howard, R O’Driscoll
Breathe 11 (3), 194-201, 2015
|Simvastatin as a treatment for pulmonary hypertension trial|
MR Wilkins, O Ali, W Bradlow, J Wharton, A Taegtmeyer, CJ Rhodes, ...
American journal of respiratory and critical care medicine 181 (10), 1106-1113, 2010
|Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension|
CJ Rhodes, J Wharton, RA Boon, T Roexe, H Tsang, B Wojciak-Stothard, ...
American journal of respiratory and critical care medicine 187 (3), 294-302, 2013
|Echocardiographic assessment of pulmonary hypertension: standard operating procedure|
LS Howard, J Grapsa, D Dawson, M Bellamy, JB Chambers, ND Masani, ...
European Respiratory Review 21 (125), 239-248, 2012
|Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort|
JE Cannon, L Su, DG Kiely, K Page, M Toshner, E Swietlik, C Treacy, ...
Circulation 133 (18), 1761-1771, 2016
|Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia|
TJ Corte, GJ Keir, K Dimopoulos, L Howard, PA Corris, L Parfitt, C Foley, ...
American journal of respiratory and critical care medicine 190 (2), 208-217, 2014
|Identification of rare sequence variation underlying heritable pulmonary arterial hypertension|
S Gräf, M Haimel, M Bleda, C Hadinnapola, L Southgate, W Li, J Hodgson, ...
Nature communications 9 (1), 1-16, 2018
|Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo …|
HA Ghofrani, G Simonneau, AM D'Armini, P Fedullo, LS Howard, X Jaïs, ...
The Lancet Respiratory Medicine 5 (10), 785-794, 2017
|Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients|
ED Michelakis, V Gurtu, L Webster, G Barnes, G Watson, L Howard, ...
Science Translational Medicine 9 (413), 2017